QuantuMDx: Leadership changes and business update

QuantuMDx today announces a business update and the appointments of Jonathan O’Halloran as Chief Executive Officer and Neil Butler as Chairman of the Board, as the company begins its transition

Share
QuantuMDx & St George’s begin field study: cervical cancer screening test

 To coincide with Cervical Cancer Prevention Week, QuantuMDx Group has announced the start of a field study with St George’s, University of London, to evaluate its human papilloma virus (HPV)

Share
Combatting cervical cancer through early HPV diagnosis

To mark the start of Cervical Cancer Prevention Week, we’ve devised an infographic to outline the burden of cervical cancer in low and middle income countries and highlight the need

Share
Tackling challenges to end tuberculosis

Next week, world leaders will meet to take part in the first UN High Level Meeting on TB, in history. As QuantuMDx is the only UK company accredited to attend

Share
QuantuMDx announces executive appointments

  QuantuMDx Group Ltd today announced two key leadership appointments. Dr Allan Brown has been appointed Chief Operating Officer and David Matthews joins as Chief Financial Officer. “These appointments represent the

Share